The association between pancreas steatosis and metabolic syndrome: A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2019 at "Diabetes/Metabolism Research and Reviews"
DOI: 10.1002/dmrr.3142
Abstract: Pancreas steatosis is the description of fat accumulation in the pancreatic gland. The prevalence and development mechanisms of pancreatic steatosis in patients with metabolic disorders still remain unclear. The aim of this study is to… read more here.
Keywords: association pancreas; pancreas steatosis; metabolic syndrome; steatosis metabolic ... See more keywords
Prevention of hepatic fibrosis with liver microsomal triglyceride transfer protein deletion in liver fatty acid binding protein null mice
Sign Up to like & getrecommendations! Published in 2017 at "Hepatology"
DOI: 10.1002/hep.28941
Abstract: Blocking hepatic very low‐density lipoprotein secretion through genetic or pharmacologic inhibition of microsomal triglyceride transfer protein (Mttp) causes hepatic steatosis, yet the risks for developing hepatic fibrosis are poorly understood. We report that liver‐specific Mttp… read more here.
Keywords: fibrosis; mttp; binding protein; mice ... See more keywords
Relationship Among Fatty Liver, Specific and Multiple‐Site Atherosclerosis, and 10‐Year Framingham Score
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology"
DOI: 10.1002/hep.30223
Abstract: Despite a well‐documented increase in the prevalence of subclinical atherosclerosis in patients with steatosis, the relationship among steatosis and atherosclerosis, specific atherosclerotic sites, multiple‐site atherosclerosis, and cardiovascular risk prediction is incompletely understood. We studied the… read more here.
Keywords: site; steatosis; multiple site; site atherosclerosis ... See more keywords
Hepatic Interferon Regulatory Factor 6 Alleviates Liver Steatosis and Metabolic Disorder by Transcriptionally Suppressing Peroxisome Proliferator‐Activated Receptor γ in Mice
Sign Up to like & getrecommendations! Published in 2019 at "Hepatology"
DOI: 10.1002/hep.30559
Abstract: Nonalcoholic fatty liver disease (NAFLD) has become a worldwide epidemic. A large and growing unmet therapeutic need has inspired numerous studies in the field. Integrating the published genomic data available in the Gene Expression Omnibus… read more here.
Keywords: interferon regulatory; regulatory factor; irf6; mice ... See more keywords
Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Ultrasound in Medicine"
DOI: 10.1002/jum.15991
Abstract: We aimed to evaluate the accuracy of the hepatorenal index by B‐mode ratio to diagnose hepatic steatosis, compared to ultrasound steatosis score, controlled attenuation parameter, and the fatty liver index using histology as the gold… read more here.
Keywords: index; fatty liver; steatosis; mode ratio ... See more keywords
Hepatic steatosis after pediatric liver transplant
Sign Up to like & getrecommendations! Published in 2017 at "Liver Transplantation"
DOI: 10.1002/lt.24773
Abstract: Hepatic steatosis develops after liver transplantation (LT) in 30% of adults, and nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in nontransplanted children. However, posttransplant steatosis has been minimally studied in… read more here.
Keywords: hepatic steatosis; biopsy steatosis; transplant; liver ... See more keywords
Can negligible hepatic steatosis determined by magnetic resonance imaging–proton density fat fraction obviate the need for liver biopsy in potential liver donors?
Sign Up to like & getrecommendations! Published in 2018 at "Liver Transplantation"
DOI: 10.1002/lt.24965
Abstract: The purpose of this study is to determine whether magnetic resonance (MR)–proton density fat fraction (PDFF) estimate of negligible hepatic fat percentage ( read more here.
Keywords: hepatic steatosis; magnetic resonance; pdff; liver biopsy ... See more keywords
Noninvasive assessment of liver steatosis in deceased donors: A pilot study
Sign Up to like & getrecommendations! Published in 2018 at "Liver Transplantation"
DOI: 10.1002/lt.25002
Abstract: The growing imbalance between the need and the availability of liver donors has resulted in an increasing use of extended liver criteria donors, which are more likely to have hepatic steatosis (HS) with a risk… read more here.
Keywords: liver steatosis; pilot study; liver procurement; liver ... See more keywords
Heterogeneity of hepatic steatosis definitions and reporting of donor liver frozen sections among pathologists: A multicenter survey
Sign Up to like & getrecommendations! Published in 2022 at "Liver Transplantation"
DOI: 10.1002/lt.26466
Abstract: To the editor, The demand for donor livers continues to increase. Strategies to increase the donor liver pool include increasing donor registration, using living donors, and using “extended criteria” for donor livers. One such extended… read more here.
Keywords: steatosis; donor; hepatic steatosis; heterogeneity hepatic ... See more keywords
Vibration‐controlled transient elastography for noninvasive evaluation of liver steatosis
Sign Up to like & getrecommendations! Published in 2022 at "Medical Physics"
DOI: 10.1002/mp.15484
Abstract: Abstract Background Nonalcoholic fatty liver disease (NAFLD) refers to a large spectrum of liver disorders and is the most common cause of metabolic liver disease. The current gold standard for diagnosing NAFLD is liver biopsy,… read more here.
Keywords: vibration controlled; liver; transient elastography; controlled transient ... See more keywords
Protective effects of propolis on hepatic steatosis and fibrosis among patients with nonalcoholic fatty liver disease (NAFLD) evaluated by real‐time two‐dimensional shear wave elastography: A randomized clinical trial
Sign Up to like & getrecommendations! Published in 2020 at "Phytotherapy Research"
DOI: 10.1002/ptr.6937
Abstract: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, while no drugs have been approved for its treatment. The pieces of evidence indicate that propolis as a novel anti‐inflammatory agent might be… read more here.
Keywords: liver disease; hepatic steatosis; steatosis fibrosis; steatosis ... See more keywords